• 1. An atomic scale study of defects in Co2FeAl
  Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886
• 2. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 3. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
• 4. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 5. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399

• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Isoflavonoids Hydroxyisoflavonoids Hydroxyisoflavonoids
• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Isoflavonoids Hydroxyisoflavonoids

Recent Advances in the Study of 2H-1-Benzopyran-2-one,4,5,7-trihydroxy-3-phenyl- (CAS: 4222-02-0): A Comprehensive Research Brief

The compound 2H-1-Benzopyran-2-one,4,5,7-trihydroxy-3-phenyl-, commonly referred to by its CAS number 4222-02-0, has garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. Recent studies have explored its pharmacological activities, synthetic pathways, and mechanisms of action, providing valuable insights for drug development and biomedical applications.

One of the most notable findings in recent research is the compound's potent antioxidant and anti-inflammatory properties. A 2023 study published in the *Journal of Medicinal Chemistry* demonstrated that 4222-02-0 exhibits strong free radical scavenging activity, which could be leveraged in the treatment of oxidative stress-related diseases such as neurodegenerative disorders and cardiovascular diseases. The study utilized in vitro assays and molecular docking simulations to elucidate the compound's interaction with key enzymes involved in oxidative pathways.

In addition to its antioxidant effects, 4222-02-0 has shown promising anticancer activity. Research conducted by a team at the National Cancer Institute revealed that the compound induces apoptosis in several cancer cell lines, including breast and lung cancer, through the modulation of the PI3K/AKT signaling pathway. These findings were further supported by in vivo studies using murine models, where the compound demonstrated significant tumor growth inhibition with minimal toxicity to normal cells.

The synthetic chemistry community has also made strides in optimizing the production of 4222-02-0. A recent publication in *Organic Letters* detailed a novel, high-yield synthesis route that employs green chemistry principles, reducing the reliance on hazardous reagents and improving the overall sustainability of the process. This advancement is particularly relevant for scaling up production for preclinical and clinical studies.

Despite these promising developments, challenges remain in the clinical translation of 4222-02-0. Pharmacokinetic studies indicate that the compound has low bioavailability, prompting researchers to explore formulation strategies such as nanoparticle encapsulation and prodrug derivatization. Ongoing research aims to address these limitations while further elucidating the compound's mechanism of action and potential off-target effects.

In conclusion, the latest research on 2H-1-Benzopyran-2-one,4,5,7-trihydroxy-3-phenyl- (CAS: 4222-02-0) highlights its multifaceted therapeutic potential and underscores the need for continued investigation. Future studies should focus on optimizing its pharmacological profile and advancing it through the drug development pipeline to harness its full clinical potential.

• 1786-05-6(2H-1-Benzopyran-2-one,4-hydroxy-3-phenyl-)
• 19225-17-3(4,7-dihydroxy-3-phenyl-2H-chromen-2-one)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)